Your session is about to expire
← Back to Search
Study Summary
This trial will help researchers understand how the visual system changes after a stroke, and how to better restore vision for people suffering from cortical blindness.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am willing and able to give my consent for treatment.I am not on any brain-affecting meds that would interfere with the study.You have difficulty paying attention to one side of your body or surroundings.You have brain damage that could make it harder for you to learn or affect the study results.My condition involves widespread brain deterioration.Your vision with glasses or contacts is worse than 20/40 in either eye.I cannot do the required visual exercises.I had a stroke affecting my vision less than 6 months ago, confirmed by MRI or CT scan.You have problems with memory or thinking, or have seizures.I can safely have an MRI scan.You have had a head injury in the past.I have significant vision loss in both eyes confirmed by specific eye tests.You can focus on a visual target for at least 1000ms. This will be checked during the study.I am willing and able to do daily visual exercises at home for months.I have had eye problems that affect my sight.You have damage to a specific part of the brain, as seen on MRI or CT scans.You have a record of using drugs or alcohol excessively.
- Group 1: Training in the blind field
- Group 2: Training in the intact field
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many participants has this research project enrolled thus far?
"Affirmative. Clinicaltrials.gov confirms that this study, which was first listed on July 19th 2021 is actively recruiting 60 participants from a single medical center. The most recent update to the trial's information was made on October 4th 2022."
To whom is this research project open for participation?
"This clinical study is recruiting 60 individuals aged between 21 and 75 who have experienced a hemorrhagic stroke. Participants must be mentally competent, willing to complete their visual training on their own for multiple months, as well as possess reliable visual field defects that can accommodate a 5-degree diameter stimulus measured by Humphrey's Perimetry, Macular Integrity Assessment (MAIA), Goldmann or equivalent techniques."
Is this research program currently recruiting participants?
"Affirmative. The clinicaltrials.gov portal states this medical experiment, which was first made available on July 19th 2021, is proactively recruiting enrollees. Approximately 60 participants are needed at 1 trial site."
Is the eligibility for this medical study restricted to those over 65 years of age?
"The age-range for this trial is 21 to 75. Those who are younger than that must look into one of the 44 different trials available; those over 65 can consider any of the 1065 other studies on offer."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger